Literature DB >> 12426768

Lipid-based vehicle for oral drug delivery.

M Stuchlík1, S Zák.   

Abstract

With an increasing number of lipophilic drugs under development, homolipids and heterolipids have gained renewed interests as excipients for oral drug delivery systems. Oral administration has many advantages for chronic drug therapy. It is relatively safe, convenient for the patient and allows self administration. This article is not intended to review the broad area of lipid-based vehicle for oral drug delivery comprehensively. The rationale behind choosing lipids materials for pharmaceutical dosage forms and their applications is discussed. It also comments on the methods for monitoring the physicochemical properties of vehicles and formulations and describes a range of pharmacopoeial excipients suitable for these purposes. The excipients selected here are pharmacopoeial in European Pharmacopoeia 4th Ed., United States Pharmacopoeia 24th Ed./National Formulary 19th Ed. and Japanese Pharmacopoeia 13th Ed. or are drafted in Pharmaeuropa and Pharmacopoeial Forum. Widening availability of lipidic excipients with specific characteristics offer flexibility of application with respect to improving the bioavailability of poorly water-soluble drugs and manipulating release profiles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12426768

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  11 in total

1.  Lipid effects on expulsion rate of amphotericin B from solid lipid nanoparticles.

Authors:  See Wei Tan; Nashiru Billa
Journal:  AAPS PharmSciTech       Date:  2013-12-07       Impact factor: 3.246

2.  Formulation, release characteristics and bioavailability study of oral monolithic matrix tablets containing carbamazepine.

Authors:  Nahla S Barakat; Ibrahim M Elbagory; Alanood S Almurshedi
Journal:  AAPS PharmSciTech       Date:  2008-08-07       Impact factor: 3.246

3.  A simple quantitative approach for the determination of long and medium chain lipids in bio-relevant matrices by high performance liquid chromatography with refractive index detection.

Authors:  Kathy Wai Yu Lee; Christopher J H Porter; Ben J Boyd
Journal:  AAPS PharmSciTech       Date:  2013-06-04       Impact factor: 3.246

4.  Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs.

Authors:  Basavaraj K Nanjwade; Didhija J Patel; Ritesh A Udhani; Fakirappa V Manvi
Journal:  Sci Pharm       Date:  2011-08-07

5.  Evaluation of Lipid-based Drug Delivery System (Phytosolve) on Oral Bioavailability of Dibudipine.

Authors:  Fariborz Keyhanfar; Samira Khani; Shahab Bohlooli
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 6.  Lipid peroxidation: Its effects on the formulation and use of pharmaceutical emulsions.

Authors:  Ramona Khanum; Haema Thevanayagam
Journal:  Asian J Pharm Sci       Date:  2017-05-06       Impact factor: 6.598

7.  Development and Evaluation of Novel Self-Nanoemulsifying Drug Delivery Systems Based on a Homolipid from Capra hircus and Its Admixtures with Melon Oil for the Delivery of Indomethacin.

Authors:  Nicholas C Obitte; Kenneth C Ofokansi; Franklin C Kenechukwu
Journal:  J Pharm (Cairo)       Date:  2014-03-20

8.  Development and characterization of dilutable self-microemulsifying premicroemulsion systems (SMEPMS) as templates for preparation of nanosized particulates.

Authors:  Shen-Fu Lin; Ying-Chen Chen; Hsiu-O Ho; Wei-Yu Huang; Ming-Thau Sheu; Der-Zen Liu
Journal:  Int J Nanomedicine       Date:  2013-09-11

9.  Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.

Authors:  Anand Kumar Kushwaha; Parameswara Rao Vuddanda; Priyanka Karunanidhi; Sanjay Kumar Singh; Sanjay Singh
Journal:  Biomed Res Int       Date:  2013-10-20       Impact factor: 3.411

10.  Design and development of cefdinir niosomes for oral delivery.

Authors:  Saurabh Bansal; Geeta Aggarwal; Pankaj Chandel; S L Harikumar
Journal:  J Pharm Bioallied Sci       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.